TSE:3407Chemicals
How Investors Are Reacting To Asahi Kasei (TSE:3407) Share Buyback And FO–MD Scale-Up In Pharma
In the past quarter, Asahi Kasei completed a share repurchase of 10,201,200 shares, or 0.75% of its stock, for ¥17,861.47 million under the buyback plan announced in November 2025, while Peptistar began operating Asahi Kasei’s forward osmosis–membrane distillation system at manufacturing scale for active pharmaceutical ingredient production.
This client adoption highlights real-world use of Asahi Kasei’s FO–MD technology, which aims to enable gentle, efficient, GMP-compatible concentration...